View in EDS PDF Full Text

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.

Saved in:
Bibliographic Details
Title: Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
Authors: Flórez-Grau G; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Zubizarreta I; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Cabezón R; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Villoslada P; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Benitez-Ribas D; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.
Source: Frontiers in immunology [Front Immunol] 2018 May 31; Vol. 9, pp. 1169. Date of Electronic Publication: 2018 May 31 (Print Publication: 2018).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29904379
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Flórez-Grau+G%22">Flórez-Grau G</searchLink>; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Zubizarreta+I%22">Zubizarreta I</searchLink>; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cabezón+R%22">Cabezón R</searchLink>; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villoslada+P%22">Villoslada P</searchLink>; Neuroimmunology Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Benitez-Ribas+D%22">Benitez-Ribas D</searchLink>; Department of Immunology, Hospital Clinic i Provincial, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2018 May 31; Vol. 9, pp. 1169. <i>Date of Electronic Publication: </i>2018 May 31 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-3224 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29904379
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2018.01169
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1169
    Titles:
      – TitleFull: Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Flórez-Grau G
      – PersonEntity:
          Name:
            NameFull: Zubizarreta I
      – PersonEntity:
          Name:
            NameFull: Cabezón R
      – PersonEntity:
          Name:
            NameFull: Villoslada P
      – PersonEntity:
          Name:
            NameFull: Benitez-Ribas D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 05
              Text: 2018 May 31
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 9
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1